Mesa Laboratories, Inc.
Mesa Laboratories, Inc. (MLAB) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
mlab · pe ratio · data through Mar 31, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Mesa Laboratories, Inc. (MLAB) measures how much investors pay for each dollar of the company's trailing earnings. MLAB's current PE ratio of 89.59x is calculated by dividing its stock price of $108.46 by its TTM earnings per share of $1.21. −83.3% discount vs 5Y avg 537.3x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-03-31
PE Ratio History
2007 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 17 fiscal years · Front-end computedMinQ1 · 25%31.1x
MedianQ3 · 75%999.7x
Max
At 89.59x, MLAB's current P/E is within its average historical range over the past 17 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Hardware, Equipment & Parts · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Mesa Laboratories, Inc.You MLAB | $599M | 89.59x | +1395.9% | $1.21 |
 Blaize Holdings, Inc. BZAI | $191M | N/A | — | -$1.98 |
 eGain Corporation EGAN | $205M | 5.46x | -8.9% | $1.15 |
 GDEV Inc. GDEV | $236M | 3.92x | -34.5% | $3.82 |
 Gorilla Technology Group Inc. GRRR | $422M | N/A | — | -$0.51 |
 Gravity Co., Ltd. GRVY | $407M | 8.59x | +43.4% | $9708.45 |
 LightPath Technologies, Inc. LPTH | $720M | N/A | — | -$0.36 |
Industry Average 3 peers with valid PE | — | 5.99x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-03-31Latest FY2026 | 72.64x | $1.22 | — | |
2025-03-31 FY2025 | — | $-0.36 | — | |
2024-03-31 FY2024 | — | $-47.20 | — | |
2023-03-31 FY2023 | 999.72x | $0.17 | +40.8% | |
2022-03-31 FY2022 | 710.01x | $0.36 | +91.9% | |
2021-03-31 FY2021 | 370.01x | $0.66 | -30.7% | |
2020-03-31 FY2020 | 534.07x | $0.42 | +354.9% | |
2019-03-31 FY2019 | 117.41x | $1.95 | — | |
2018-03-31 FY2018 | — | $-0.79 | — | |
2017-03-31 FY2017 | 40.37x | $3.04 | +29.8% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Mesa Laboratories, Inc. (MLAB) measures how much investors pay for each dollar of the company's trailing earnings. MLAB's current PE ratio of 89.59x is calculated by dividing its stock price of $108.46 by its TTM earnings per share of $1.21.
Frequently asked questions
MLAB pe ratio · 6 questionsMLAB's current PE ratio is 89.59x as of 2026-06-08, based on a stock price of $108.46 and TTM EPS of $1.21. Data sourced from Financial Modeling Prep via MLAB's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Mesa Laboratories, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08